Aquaporin-4 Gene Silencing Protects Injured Neurons After Early Cerebral Infarction
Overview
Authors
Affiliations
Aquaporin-4 regulates water molecule channels and is important in tissue regulation and water transportation in the brain. Upregulation of aquaporin-4 expression is closely related to cellular edema after early cerebral infarction. Cellular edema and aquaporin-4 expression can be determined by measuring cerebral infarct area and apparent diffusion coefficient using diffusion-weighted imaging (DWI). We examined the effects of silencing aquaporin-4 on cerebral infarction. Rat models of cerebral infarction were established by occlusion of the right middle cerebral artery and siRNA-aquaporin-4 was immediately injected via the right basal ganglia. In control animals, the area of high signal intensity and relative apparent diffusion coefficient value on T2-weighted imaging (T2WI) and DWI gradually increased within 0.5-6 hours after cerebral infarction. After aquaporin-4 gene silencing, the area of high signal intensity on T2WI and DWI reduced, relative apparent diffusion coefficient value was increased, and cellular edema was obviously alleviated. At 6 hours after cerebral infarction, the apparent diffusion coefficient value was similar between treatment and model groups, but angioedema was still obvious in the treatment group. These results indicate that aquaporin-4 gene silencing can effectively relieve cellular edema after early cerebral infarction; and when conducted accurately and on time, the diffusion coefficient value and the area of high signal intensity on T2WI and DWI can reflect therapeutic effects of aquaporin-4 gene silencing on cellular edema.
Balaji P, Bhimrao L, Yadav A Mol Neurobiol. 2024; 62(1):184-220.
PMID: 38829514 DOI: 10.1007/s12035-024-04215-3.
Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far?.
Freire M, Rocha G, Bittencourt L, Falcao D, Lima R, Cavalcanti J Biology (Basel). 2023; 12(8).
PMID: 37627023 PMC: 10452099. DOI: 10.3390/biology12081139.
The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment.
Lv T, Zhao B, Hu Q, Zhang X Front Aging Neurosci. 2021; 13:689098.
PMID: 34305569 PMC: 8297504. DOI: 10.3389/fnagi.2021.689098.
Kang E, Cho S, Lim C, Lee B, Kim Y, Kim K Pharm Biol. 2021; 59(1):840-853.
PMID: 34184969 PMC: 8245089. DOI: 10.1080/13880209.2021.1941130.
Shi Z, Fang Q, Chen Y, Xu L, Wu M, Jia M Acta Pharmacol Sin. 2020; 42(3):382-392.
PMID: 32665706 PMC: 8027449. DOI: 10.1038/s41401-020-0468-5.